Oncology & Cancer

Herd protection against oral HPV infections seen among men

In unvaccinated men aged 18 to 59 years, the prevalence of vaccine-type oral human papillomavirus (HPV) decreased between 2009 to 2010 and 2015 to 2016, according to a research letter published in the Sept. 10 issue of the ...

Diseases, Conditions, Syndromes

Coverage with HPV vaccine continuing to increase in boys

(HealthDay)—Coverage with the human papillomavirus (HPV) vaccine increased among boys from 2017 to 2018, according to research published in the Aug. 23 issue of the U.S. Centers for Disease Control and Prevention Morbidity ...

Oncology & Cancer

Most HPV-linked cancers due to types targeted by 9vHPV vaccine

(HealthDay)—Ninety-two percent of human papillomavirus (HPV)-related cancers are attributable to HPV types targeted by the 9-valent HPV vaccine (9vHPV), according to research published in the Aug. 23 issue of the U.S. Centers ...

Diseases, Conditions, Syndromes

ACIP recommends catch-up HPV vaccines through age 26

(HealthDay)—Catch-up human papillomavirus (HPV) vaccinations are recommended for all persons through age 26 years and should be considered for some persons aged 27 to 45 years, according to research published in the Aug. ...

Diseases, Conditions, Syndromes

Targeted interventions raise HPV vaccine acceptance in women

(HealthDay)—Among young women, targeted educational interventions, particularly educational videos, increase human papillomavirus (HPV) vaccine acceptability and knowledge, according to a study published online July 9 in ...

Medical research

Mouth rinse for HPV DNA may be biomarker in head, neck cancer

(HealthDay)—Human papillomavirus (HPV) DNA detected from a mouth rinse may be an effective marker for prognosis during treatment of HPV-positive head and neck cancer, according to a study recently published in JAMA Oncology.

page 16 from 40